SPRC
Scisparc LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$5.34M
P/E Ratio
0.09
EPS
$98.07
Beta
2.43
52W High
$80.10
52W Low
$2.98
50-Day MA
$6.29
200-Day MA
$15.50
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Scisparc Ltd
SciSparc Ltd., a specialized clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. The company is headquartered in Tel Aviv, Israel.
Fundamentals
| Revenue (TTM) | 856,000 |
| Gross Profit (TTM) | 631,000 |
| EBITDA | $-8.53M |
| Operating Margin | -849.00% |
| Return on Equity | -178.40% |
| Return on Assets | -60.70% |
| Revenue/Share (TTM) | $6.89 |
| Book Value | $142.32 |
| Price-to-Book | 1.25 |
| Price-to-Sales (TTM) | 6.23 |
| EV/Revenue | 1.245 |
| EV/EBITDA | 1.21 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -34.50% |
| Shares Outstanding | 573,240 |
| Float | 533,290 |
| % Insiders | 0.00% |
| % Institutions | 0.57% |
Historical Volatility
HV 10-Day
88.04%
HV 20-Day
94.15%
HV 30-Day
171.96%
HV 60-Day
158.59%
HV Rank
—
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 6/13/2026